Contact Details
Proactive UK Ltd
+44 20 7989 0813
Oxford Cannabinoid Technologies: Phase 1 approval for lead chronic pain drug
May 24, 2023 at 10:59 AM EDT
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms Of Service. |
|